| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $118,106,724 ) (Continued on the next page) |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | P30HS029767 | Realizing Accelerated Progress, Investigation, Implementation, and Dissemination in Learning Health Systems (RAPID-LHS) Center | 000 | 2 | AHRQ | 12/20/2024 | $986,302 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA249863 | Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data | 000 | 5 | NIH | 12/5/2024 | $604,309 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R33GM144915 | The Sepsis ClinicAl Resource And Biorepository (SCARAB) Project | 001 | 4 | NIH | 1/28/2025 | $655,511 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DC020888 | Consequences of chronic noise exposure in nonhuman primates | 000 | 2 | NIH | 12/5/2024 | $740,096 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012268 | Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat) | 000 | 4 | NIH | 12/25/2024 | $247,793 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012268 | Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat) | 000 | 4 | NIH | 12/25/2024 | $50,000 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI069439 | Vanderbilt HIV Clinical Trials Unit (CTU) | 000 | 20 | NIH | 11/26/2024 | $215,439 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI069439 | Vanderbilt HIV Clinical Trials Unit (CTU) | 000 | 20 | NIH | 11/26/2024 | $1,144,666 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HS028430 | Realtime Measurement of Situational Workload in NICU Nurses to Improve Workload Management and Patient Safety | 000 | 4 | AHRQ | 2/10/2025 | $198,971 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI093234 | Statistical Methods for Ordinal Variables in HIV/AIDS Studies | 000 | 11 | NIH | 12/4/2024 | $600,434 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI148452 | Vanderbilt Vaccine and Treatment Evaluation Unit | 000 | 6 | NIH | 12/5/2024 | $379,651 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI148452 | Vanderbilt Vaccine and Treatment Evaluation Unit | 000 | 6 | NIH | 12/5/2024 | $621,717 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23HL151871 | The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease | 000 | 5 | NIH | 1/20/2025 | $185,436 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL161095 | Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension | 000 | 4 | NIH | 12/5/2024 | $604,522 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK131104 | Obesogenic diet-induced intestinal epithelium repair responses link dysbiosis and cardiovascular disease | 000 | 4 | NIH | 12/17/2024 | $441,231 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HS029331 | Reducing Overuse of Antibiotics with Decision Support: The ROADS Study | 000 | 3 | AHRQ | 1/22/2025 | $250,000 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DC020194 | Binaural cue sensitivity in children and adults with combined electric and acoustic stimulation | 000 | 3 | NIH | 11/27/2024 | $596,727 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 002 | 1 | NIH | 1/31/2025 | $172,376 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 002 | 1 | NIH | 1/31/2025 | $21,827,624 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R35GM141927 | Protection Against Nosocomial Infections After Severe Burn Injury Through Trained Immunity | 001 | 4 | NIH | 1/23/2025 | $49,761 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA289528 | Molecular Mediators of Cell-free DNA biogenesis | 000 | 1 | NIH | 12/16/2024 | $670,147 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012468 | Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program | 000 | 3 | NIH | 12/16/2024 | $247,072 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK105550 | Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease | 000 | 13 | NIH | 1/23/2025 | $366,251 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U54AG089326 | Vanderbilt-coordinated human Virome Collaborative Center (V2C2) | 000 | 1 | NIH | 1/22/2025 | $3,984,525 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R34MH132711 | Developing and testing a text-messaging intervention to support parents after their child's psychiatric emergency | 000 | 2 | NIH | 1/23/2025 | $226,159 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI167789 | Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients | 000 | 4 | NIH | 1/22/2025 | $794,913 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | P01HL116263 | HDL Function in Human Disease | 000 | 10 | NIH | 1/22/2025 | $2,303,452 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08NS140767 | Neurophysiology of Reward Signaling in Parkinson's Disease | 000 | 1 | NIH | 12/16/2024 | $176,079 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK133512 | Hepatic stellate cells in liver homeostasis and regeneration | 000 | 2 | NIH | 11/18/2024 | $612,559 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DC020186 | Sensory Project in Infant/Toddler Siblings of Children with Autism (Project SPIS) | 000 | 3 | NIH | 12/10/2024 | $74,170 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01NS134625 | Development of multimodal network analyses to improve epilepsy surgery outcomes | 001 | 2 | NIH | 11/15/2024 | $88,054 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K99LM014429 | Development and implementation of statistical machine learning methods to shorten rare disease odysseys | 000 | 2 | NIH | 12/9/2024 | $90,612 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01EY024997 | Mechanisms of Adaptive Remodeling and Their Therapeutic Potential in Glaucoma | 000 | 9 | NIH | 12/19/2024 | $452,370 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL171577 | The Road to Destination Therapy: Developing a Durable Ambulatory Mechanical Cardiopulmonary Support for Pulmonary Hypertension | 000 | 2 | NIH | 1/18/2025 | $671,339 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01MH132022 | Next generation transcranial ultrasound-based neuromodulation using phase shift nanoemulsions | 000 | 3 | NIH | 12/19/2024 | $659,268 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG076785 | Common Inflammation Pathways between Aging and Hypertension That Weaken Bone | 000 | 4 | NIH | 1/3/2025 | $453,730 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23DK135414 | Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV | 000 | 3 | NIH | 1/17/2025 | $185,436 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI182247 | Role of IgE in human disease and immunity to ticks | 000 | 2 | NIH | 2/13/2025 | $726,387 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | AY2AX000077 | AI-Enabled Generation of Antigen-Specific Antibodies | 000 | 1 | NIH | 1/17/2025 | $17,258,990 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08HG014001 | A high-throughput, multimodal strategy to improve variant classification | 000 | 1 | NIH | 1/3/2025 | $172,584 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08DA058046 | Measuring and modifying delay discounting as a mechanism of smoking in pregnancy | 000 | 2 | NIH | 1/17/2025 | $185,064 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R35HL144980 | Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia | 000 | 7 | NIH | 1/24/2025 | $918,000 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01NS092961 | Resting State Connectivity in Primate Spinal Cord | 000 | 11 | NIH | 1/17/2025 | $506,305 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL167969 | Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials | 000 | 2 | NIH | 12/30/2024 | $664,507 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 2 | NIH | 11/22/2024 | $18,104 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 2 | NIH | 11/22/2024 | $150,000 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 2 | NIH | 11/22/2024 | $80,000 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012750 | Vanderbilt-Mozambique Biomedical Informatics (VM-BMI) Training and Research Program | 000 | 2 | NIH | 12/11/2024 | $302,374 |
| | 2025 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R38HL167237 | Vanderbilt Stimulating Access to Research in Residency (V-StARR) | 000 | 3 | NIH | 1/17/2025 | $340,885 |
|
